Skip to main content
Natco Pharma Ltd. logo

Natco Pharma Ltd. — Investor Relations & Filings

Ticker · NATCOPHARM ISIN · INE987B01026 LEI · 33580086GIBRWXSNGG39 BSE.NS Manufacturing
Open in API
Filings indexed 1,708 across all filing types
Latest filing 2020-04-08 Regulatory Filings
Country IN India
Listing BSE.NS NATCOPHARM

About Natco Pharma Ltd.

https://www.natcopharma.co.in/

Natco Pharma Ltd. is a vertically integrated organization focused on the development, manufacturing, and marketing of complex generics and active pharmaceutical ingredients (APIs). The company specializes in niche therapeutic areas, maintaining a leadership position in oncology and a significant presence in specialty segments such as hepatology, cardiology, and diabetology. Natco is recognized for its expertise in high-barrier-to-entry products, including complex oral solids and injectables. Its business model emphasizes research and development to deliver affordable versions of life-saving medicines globally. With a robust portfolio of finished dosage formulations and a strong supply chain for APIs, the company serves diverse international markets, including North America, Europe, and emerging economies, through strategic partnerships and direct distribution channels.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-04-08 English
Closure of Trading Window
Regulatory Filings
2020-03-31 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the closure of the trading window for insiders ahead of the financial results announcement for the quarter and year ended March 31, 2020. It does not contain any financial data, results, or detailed report content. It is an announcement related to compliance with insider trading regulations and timing of financial results disclosure. The document length is only 1508 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than a financial report or earnings release.
2020-03-31 English
USFDA Completes Inspection of NATCO''s Kothur Formulation Facility
Regulatory Filings
2020-03-06 English
Press Release
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no substantive text or financial data. The length is very short (260 characters), and there is no indication of any report content, announcements, or filings. Given the absence of any meaningful content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2020-03-06 English
Reply to Clarification Sought
Regulatory Filings
2020-02-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.